Home › NDC Lookup › Ingredients › Camphor Menthol Methyl Salicylate › 46581-0110-60
Salonpas Camphor, Menthol, Methyl salicylate 21.56 mg; 41.73 mg; 69.55 mg Patch, 60 patches — NDC 46581-0110-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Salonpas Camphor, Menthol, Methyl salicylate 21.56 mg; 41.73 mg; 69.55 mg Patch, 60 patches — NDC 46581-110-60 (Billing 46581-0110-60)

by Hisamitsu Pharmaceutical Co., Inc. · 3 POUCH in 1 BOX / 20 PATCH in 1 POUCH

This is a package of 60 patches of Salonpas Camphor, Menthol, Methyl salicylate 21.56 mg; 41.73 mg; 69.55 mg Patch from Hisamitsu Pharmaceutical Co., Inc., marketed since Jun 2015 and currently FDA-listed.

NDC 46581-0110-60
🏷️ FDA NDC (as labeled) 46581-110-60 billing pads the product segment with a zero
This package
Contains60 patches Pack sizes4 compare ↓
Product page 46581-0110-14 Also comes in: 2 patches 46581-110-99 20 patches 46581-110-20 140 patches 46581-110-14
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 46581-110-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
46581 labeler · 110 product · 60 package
Package marketed since
Jun 1, 2015
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
60 EA per package
Barcode (UPC-A, from the NDC)
3 4658111060 9
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 46581-110-60
Product NDC 46581-110
11-digit billing NDC 46581011060
NCPDP billing unit EA — each (per item)
RxCUI 1793147
UNII 5TJD82A1ET, L7T10EIP3A, LAV5U5022Y
Application # M017
SPL Set ID acdd5622-a9a7-4cc3-877e-57efea23303f
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-06-01
Route PERCUTANEOUS, TOPICAL, TRANSDERMAL
Dosage form PATCH
Substance CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90809903255935
GPI class Salonpas
GCN Seq No 080146
GCN 46845
HICL code 002581
Ingredient (HICL) Methyl Salicylate/Menth/Camph
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L6
Therapeutic class — intermediate (HIC2) Irritants
HIC3 code L6A
Therapeutic class — specific (HIC3) Irritants/Counter-Irritants
AHFS code 28:08.04.24
AHFS class Salicylates
FDB label name SALONPAS 3.1%-6.0%-10.0% PATCH
FDB brand name Salonpas
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 080146
  • GCN: 46845
  • GPI-14 (Medi-Span): 90809903255935
  • HICL (First Databank): 002581
  • AHFS class code: 28:08.04.24
  • RxCUI (RxNorm): 1793147
Why two NDCs? The FDA registers this code as 46581-110-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46581-0110-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name SALONPAS 3.1%-6.0%-10.0% PATCH Ingredient Methyl Salicylate/Menth/Camph
🧪 What is this product?

Salonpas is an over-the-counter topical patch containing camphor, menthol, and methyl salicylate. These three ingredients are commonly used together in pain-relief patches and are typically applied to the skin to provide a warming or cooling sensation and mild topical comfort. This is an OTC monograph product, meaning it is marketed under a standardized FDA rule-book for this category of topical analgesic patches rather than as an individually reviewed drug application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 2 patches 20 patches 140 patches
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
46581-0110-14 46581-110-14 Main listing 7 POUCH in 1 BOX / 20 PATCH in 1 POUCH 2016-08-01 — Active
46581-0110-20 46581-110-20 1 POUCH in 1 BOX / 20 PATCH in 1 POUCH 2015-12-01 — Active
46581-0110-60 You're viewing this 3 POUCH in 1 BOX / 20 PATCH in 1 POUCH 2015-06-01 — Active
46581-0110-99 46581-110-99 2 PATCH in 1 POUCH 2015-07-01 — Active

Pack size FAQ

What quantity is in this package?
This package contains 60 patches — 3 pouch in 1 box / 20 patch in 1 pouch.
How does this package differ from NDC 46581-0110-99?
Both are Salonpas Camphor, Menthol, Methyl salicylate 21.56 mg; 41.73 mg; 69.55 mg Patch — the drug itself is identical. This page's package is the 60 patches one, while NDC 46581-0110-99 is the 2 patches package.
What NDC number is used to bill for this package of Salonpas Camphor, Menthol, Methyl salicylate 21.56 mg; 41.73 mg; 69.55 mg Patch?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Large Medicate Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 46122-0645-13 Amerisource 6 patches $0.665 — Availability likely —
Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 70000-0368-01 Cardinal 6 patches $0.665 — Availability likely —
Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 00363-0907-60 Walgreen 60 patches — — FDA listed —
Walgreens Pain Relieving Patch 100 mg/g; 31 mg/g; 60 mg/g 00363-6716-06 Walgreen 6 patches — — FDA listed —
Large Pain Relieving 3.1 g/100g; 6 g/100g; 10 g/100g 00363-9904-06 Walgreen 6 pouches — — FDA listed —
Pain Relief Medicated 3.1 g/100g; 6 g/100g; 10 g/100g 11822-7883-03 RITE 60 pouches — — FDA listed —
Medicated Pain Relief Patch 3.1 g/100g; 6 g/100g; 10 g/100g 30142-0892-60 Kroger 60 patches — — FDA listed —
Topcare Medicated Pain Relieving Patch 60ct 60 mg/g; 31 mg/g; 100 mg/g 36800-0750-60 Topco 1 pouch — — FDA listed —
Large Medicated Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 41250-0833-05 Meijer 6 patches — — FDA listed —
Medicated Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 41250-0907-60 Meijer 60 patches — — FDA listed —
Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 46122-0392-58 Amerisource 40 patches — — Discontinued —
Salonpas 21.56 mg/1; 41.73 mg/1; 69.55 mgthis 46581-0110-60 Hisamitsu 60 patches — — FDA listed —
Salonpas 86.24 mg/1; 166.92 mg/1; 278.2 mg 46581-0210-06 Hisamitsu 6 patches — — FDA listed —
Pain-Relieving Patch 60 mg/g; 100 mg/g; 31 mg/g 51316-0280-60 CVS 180 patches — — FDA listed —
CVS Health Pain-Relieving Patch 10 g/100g; 3.1 g/100g; 6 g/100g 51316-0992-06 CVS 6 patches — — FDA listed —
Medicated Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 53943-0907-60 Discount 60 patches — — FDA listed —
Solstice Pain Relieving 3.1 g/100g; 6 g/100g; 10 g/100g 55614-0210-02 MADISON 2 patches — — FDA listed —
Solstice Pain Relieving 3.1 g/100g; 6 g/100g; 10 g/100g 55614-0310-06 MADISON 6 patches — — FDA listed —
Dollar General Medicated Pain Relief Patch 3.1 g/100g; 6 g/100g; 10 g/100g 55910-0907-20 DOLGENCORP, 20 patches — — FDA listed —
HealthWise 3x Medicated Pain Relief Patch 120 Bulk 10 g/1; 3.1 g/1; 6 g 71101-0032-12 Veridian 120 patches — — FDA listed —
HealthWise 3x Medicated Pain Relief Patch 10 g/1; 3.1 g/1; 6 g 71101-0034-01 Veridian 18 patches — — FDA listed —
TheraCare Medicated Pain Relief 6 g/100g; 3.1 g/100g; 10 g/100g 71101-0128-01 Veridian 60 patches — — FDA listed —
TheraCare Medicated Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 71101-0909-06 Veridian 6 patches — — FDA listed —
AsperFlex Advance 86.24 mg/1; 166.92 mg/1; 278.2 mg 71399-4458-06 Akron 6 patches — — FDA listed —
Pain Relief Patches 3.1 g/100g; 6 g/100g; 10 g/100g 72036-0907-60 Harris 60 patches — — FDA listed —
Bonica EaseX Pain Relieving 31 mg/g; 60 mg/g; 100 mg/g 75568-0036-01 Planet 360 patches — — FDA listed —
Careland Pain Relief Plus 31 mg/g; 60 mg/g; 100 mg/g 75568-0039-01 Planet 56 pouches — — FDA listed —
Careland Kinesiology Pain Relieving Tape 31 mg/g; 60 mg/g; 100 mg/g 75568-0049-00 Planet 20 patches — — FDA listed —
Equate Pain Relief Patch Camphor/Menthol/Salicylate 3.1 g/100g; 6 g/100g; 10 g/100g 79903-0039-60 Walmart 60 pouches — — FDA listed —
Equate Medicated Pain Relieving Patch, Large 6-Count 3.1 g/100g; 6 g/100g; 10 g/100g 79903-0308-06 Walmart 6 pouches — — FDA listed —
Sc Herbal .06 g/g; .1 g/g; .031 g/g 82198-0015-01 Big 3 patches — — FDA listed —
Pain Relief Patch 3.1 g/1; 6 g/1; 10 g 83324-0255-60 CDMA, 60 patches — — FDA listed —
Pain 10 g/1001; 3.1 g/1001; 6 g/1001 87255-0005-01 Shenzhen 1 patch — — FDA listed —
Pure-Aid 21.56 mg/1; 41.73 mg/1; 69.55 mg 67510-0289-01 Kareway 10 patches — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Jun 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII T1FAD4SS2M
    Aluminum silicate is a mineral compound used as a thickener, absorbent, and anti-caking agent in medicines. It helps give liquid or powder formulations the right texture and prevents clumping.
  • UNII T5L8T28FGP
    Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

3 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesmineral oil, perfume, polyisobutylene, styrene-isoprene-styrene block copolymer, synthetic aluminum silicate, terpene resin, titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerHisamitsu Pharmaceutical Co., Inc.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code46581
First marketedJun 2015
Product typeHuman Otc Drug
Portfolio11 products on file

More NDCs from Hisamitsu Pharmaceutical Co., Inc. labeler code 46581

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 21 words ▾

Uses For temporary relief of minor aches and pains of muscles and joints associated with: arthritis simple backache strains bruises sprains

⏱️ Dosage and Administration 50 words ▾

Directions Adults and children 12 years of age and over: clean and dry affected area remove patch from film apply to affected area not more than 3 to 4 times daily remove patch from the skin after at most 8-hour application Children under 12 years of age: consult a doctor

⚠️ Warnings 126 words ▾

Warnings For external use only Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use. Do not use on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes do not bandage tightly Stop use and ask a doctor if rash, itching or excessive skin irritation develops conditions worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 13 words ▾

Other information avoid storing product in direct sunlight protect product from excessive moisture

🧪 Active Ingredient 9 words ▾

Active ingredients Camphor 3.1% Menthol 6.0% Methyl salicylate 10.0%

🧪 Inactive Ingredients 16 words ▾

Inactive ingredients mineral oil, perfume, polyisobutylene, styrene-isoprene-styrene block copolymer, synthetic aluminum silicate, terpene resin, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Topical analgesic

📄 Do Not Use 22 words ▾

Do not use on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product

📄 Ask a Doctor Before Use If 16 words ▾

Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.

📄 When Using This Product 21 words ▾

When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes do not bandage tightly

📄 Stop Use and Ask a Doctor If 33 words ▾

Stop use and ask a doctor if rash, itching or excessive skin irritation develops conditions worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 7 words ▾

Questions or comments? Toll free 1-800-826-8861 www.salonpas.us

📄 Package Label / Principal Display Panel 92 words ▾

Principal Display Panel OTC topical analgesics in patch category* WORLD'S BRAND NO.1 Hisamitsu NDC#46581-110-60 for temporary relief of minor aches and pains STIFF NECK SORE SHOULDER BACKACHE JOINT PAIN Salonpas Pain Relieving Patch APPLY FOR 8 HOURS 60 PATCHES 2.83" X 1.81" (7.2cm X 4.6cm) MADE IN JAPAN image of 60-patch box label

Principal Display Panel CUT OPEN HERE Hisamitsu NDC#46581-110-99 Stiff Neck Sore Shoulder Backache Joint Pain Salonpas Pain Relieving Patch 2 PATCHES 2.83" X 1.81" (7.2cm X 4.6cm) SAMPLE ONLY / NOT FOR RE-SALE image of 2-patch sample pouch label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Salonpas (this brand).

Top reported reactions

Pain7,443
Fatigue7,024
Rheumatoid Arthritis6,411
Rash6,130
Abdominal Discomfort6,034
Systemic Lupus Erythematosus5,897
Alopecia5,794

Age at onset

Neonate109
Infant6
Child12
Adolescent29
Adult3,858
Elderly1,379

Reporter sex

35,533 reports
Male · 26%
Female · 74%
Unknown · 0%

Serious outcomes

Hospitalization13,394
Disabling7,224
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 4,908 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Hisamitsu Pharmaceutical Co., Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 2 patches (46581-0110-99), 20 patches (46581-0110-20), 140 patches (46581-0110-14). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Hisamitsu Pharmaceutical Co., Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 46575-0002-02 · Opocrin 46581-0210-06 · Hisamitsu →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.